• Facebook Social Icon
  • Twitter Social Icon

© 2018 by BioLargo, Inc.

Patented and innovative life sciences technologies

Full-service engineering

Clean air, clean water, advanced wound care

BioLargo Companies
Click to learn more:


Odor No More.jpg
About BioLargo

BioLargo invents, patents, and develops innovative platform technologies for three markets: 1) advanced water and wastewater treatment, 2) industrial odor and VOC control, and 3) advanced wound care products. With a wide array of issued patents, an extensive R&D talent pool, and a full-service engineering team, the company maintains a robust pipeline of products from inception through maturity.  BioLargo monetizes its technology assets with the goal of maximizing both impact and shareholder value, using licensing, strategic partnership, and direct-to-market strategies. 

BioLargo_Final Files_ 08092017.png

BioLargo Technologies

CupriDyne Clean Industrial Odor and VOC Eliminator:

  • Eliminates odors; doesn't mask them

  • Non-toxic, non-sensitizing, non-fragranced

  • Effective against VOCs, ammonia, sulfur compounds, mercaptans, fatty acids

  • Misting systems: design, build, install, maintain, service options available

Click HERE to learn more

AOS_Final Files_06042017.png

The Advanced Oxidation System (AOS):

  • Exceptional disinfection performance with concurrent decontamination

  • Ultra low energy consumption

  • Lower costs than competitors (OPEX and CAPEX)

  • Modular - Flexible - Scalable

Click HERE to learn more


Clyra Advanced Wound Care Products:

  • Infection control, chronic wound therapy, regenerative tissue therapy

  • Non-cytotoxic, safe, broad-spectrum antimicrobial action. Efficacy proven.

  • No bacterial resistance.

  • Hydrogels, dressings, liquids

  • First product FDA 510(k) approved

Click HERE to learn more


BioLargo Social Media

BioLargo Blog:

The Edison Group Analyst Reports for BioLargo


Investor Relations Page

Click the link above to access the Investor Relations Page, which includes information about BioLargo, Inc. businesses for stockholders, potential investors, and financial analysts.